PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:20 AM ET

Sponsor Check › Sponsor group

E

Elixirgen

One sponsor team, 2 deal companies · Baltimore, MD

Grouped because: 1 shared person, same business address (2 issuers), similar issuer names (2) (automatic match from the filings) · not the same sponsor?

2deal companies
$4.3Mreported sold
6investors
10Form D filings
2012–2025active
1new, last 12 mo
Follow this sponsor groupLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing in this group Nov 13, 2025 · Courts (RECAP) last checked: Oct 24, 2026, 2:16 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Elixirgen is a sponsor group of 2 issuers that PartnerFacts links to one sponsor (shared people, same business address, similar issuer names; automatic match from the filings), filing 10 Form D filings between Apr 2012 and Nov 2025.

What this means One team, 2 deal companies, about 13 years of track record in SEC filings. We link the companies because the same people or address appear on their forms — tap "Request a correction" if that is wrong.

Combined reported sold: $4.3M to 6 investors (latest filing per issuer). Industries as reported: Biotechnology (2). Issuers are based in MD (2).

What this means $4.3M raised across the group, about $717K per investor. Amounts come from each company's latest Form D; they are what the sponsor reported, not audited figures.

Principal people: Minoru Ko (2 issuers, executive officer and director), Akihiro KO (1 issuer, executive officer, director, and promoter), Hiroaki Kobayashi (1 issuer, director), Jeffrey Cleland (1 issuer, director), Maiko Katadae (1 issuer, director) and 4 more.

What this means The person on the most companies is usually the one running the show; their page lists every deal.

Activity: 1 new offering in the last 12 months; latest filing Nov 13, 2025.

What this means still raising money this year.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA), property records (NYC, FL, IL and TX counties) — none found.

What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 10 public filings for Elixirgen and found 10 differences: Form D filed 22 days after the first sale; Form D filed 16 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Elixirgen has not run yet — it is joining a line of 13,550 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Elixirgen..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:16 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.

10 differences found between the filings for Elixirgen (compared 10 filings on Oct 24, 2026)

Note · Nov 9, 2023 – Dec 1, 2023

Form D filed 22 days after the first sale — ELIXIRGEN THERAPEUTICS, INC.

The filing says the first sale was Nov 9, 2023. The Form D was filed Dec 1, 2023 — 22 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 7 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Dec 1, 2023 ↗ELIXIRGEN THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Feb 2, 2021 – Feb 18, 2021

Form D filed 16 days after the first sale — ELIXIRGEN THERAPEUTICS, INC.

The filing says the first sale was Feb 2, 2021. The Form D was filed Feb 18, 2021 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Feb 18, 2021 ↗ELIXIRGEN THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Apr 7, 2012 – Apr 23, 2012

Form D filed 16 days after the first sale — Elixirgen, LLC

The filing says the first sale was Apr 7, 2012. The Form D was filed Apr 23, 2012 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Apr 23, 2012 ↗Elixirgen, LLC — PartnerFacts page ↗
Sources
Note · Feb 18, 2021 – Dec 1, 2023

4 role changes for the same people across filings

Minoru Ko's role changed at ELIXIRGEN THERAPEUTICS, INC.: executive officer, director → director · AKIHIRO KO's role changed at ELIXIRGEN THERAPEUTICS, INC.: executive officer, director, promoter → executive officer, director · Minoru Ko's role changed at ELIXIRGEN THERAPEUTICS, INC.: director → executive officer, director · AKIHIRO KO's role changed at ELIXIRGEN THERAPEUTICS, INC.: executive officer, director → executive officer, director, promoter

What this means Roles on Form D are self-reported. Ask who runs the company today.

Form D · Sep 29, 2022 ↗Form D · Dec 1, 2023 ↗Minoru Ko — PartnerFacts page ↗ELIXIRGEN THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Dec 2, 2019 – Aug 17, 2020

Offering amount changed between filings — ELIXIRGEN THERAPEUTICS, INC.

The Dec 2, 2019 filing says $5,006,900 offered; the Aug 17, 2020 Form D/A says $5,706,889.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Dec 2, 2019 ↗Form D/A (later) · Aug 17, 2020 ↗ELIXIRGEN THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Feb 2, 2021 – Feb 18, 2021

No amendment in the last 12 months on an offering that may still be open — ELIXIRGEN THERAPEUTICS, INC. (latest filing Feb 18, 2021)

The latest filing for this offering is dated Feb 18, 2021 (first sale Feb 2, 2021). It reports $4,199,985 sold of $5,499,971 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Feb 18, 2021 ↗ELIXIRGEN THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Apr 7, 2012 – Apr 23, 2012

No amendment in the last 12 months on an offering that may still be open — Elixirgen, LLC (latest filing Apr 23, 2012)

The latest filing for this offering is dated Apr 23, 2012 (first sale Apr 7, 2012). It reports $300,000 sold of $1,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 23, 2012 ↗Elixirgen, LLC — PartnerFacts page ↗
Sources
Note · Jun 25, 2018 – Dec 1, 2023

AKIHIRO KO is written 2 different ways on the filings

listed as "Akihiro KO" on 8 filings (from Jun 25, 2018), and "Akihiro C Ko" on the Dec 1, 2023 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jun 25, 2018 ↗Form D · Dec 1, 2023 ↗AKIHIRO KO — PartnerFacts page ↗
Sources
Note · Feb 18, 2021 – Dec 1, 2023

THOMAS WHITE is written 2 different ways on the filings

listed as "Thomas White" on 5 filings (from Feb 18, 2021), and "Thomas K. White" on the Dec 1, 2023 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Feb 18, 2021 ↗Form D · Dec 1, 2023 ↗THOMAS WHITE — PartnerFacts page ↗
Sources
Note · Apr 23, 2012 – Dec 2, 2019

Minoru Ko is written 3 different ways on the filings

listed as "Minoru Shil Hong Ko" on the Apr 23, 2012 filing, and "Minoru S.h. KO" on 2 filings (from Jun 25, 2018), and "Minoru Ko" on 7 filings (from Dec 2, 2019).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 23, 2012 ↗Form D · Jun 25, 2018 ↗Form D · Dec 2, 2019 ↗Minoru Ko — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 9 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Nov 13, 2025 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-563910
$0$0$0None listed on this filingEDGAR ↗
Apr 9, 2025 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-543260
$0$0$0None listed on this filingEDGAR ↗
Feb 12, 2025 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-538043
$0$0$0None listed on this filingEDGAR ↗
Dec 1, 2023 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-498657
$0$0$0None listed on this filingEDGAR ↗
Sep 29, 2022 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-460209
$0$0$0None listed on this filingEDGAR ↗
Feb 18, 2021 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-389761
$0$0$0None listed on this filingEDGAR ↗
Aug 17, 2020 D/A
ELIXIRGEN THERAPEUTICS, INC.
File 021-354561
$0$0$0None listed on this filingEDGAR ↗
Jun 25, 2018 D
ELIXIRGEN THERAPEUTICS, INC.
File 021-315262
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2012 D
Elixirgen, LLC
File 021-177100
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across all 2 issuers in this group — every filing in our index, latest filing per offering (SEC file number).

Property records 0 documents · 0 ownership records · last checked Oct 23, 2026, 8:59 PM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to Elixirgen in the sources searched.

Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Still to be looked up for this group: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not covered). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Issuers in this group

Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.

SourceIssuerLinked byLocationIndustryFilingsSold (max)InvestorsMin. investment (latest filing)Active
EDGAR ↗E Elixirgen, LLCshared people, same business address, similar issuer namesBALTIMORE, MDBiotechnology1$300,0003$100,0002012–2012
EDGAR ↗ET ELIXIRGEN THERAPEUTICS, INC.shared people, same business address, similar issuer namesBALTIMORE, MDBiotechnology9$6,999,988
offering $4,000,000 · similar: $2,000,000–$19,999,994
3
similar: 2–16
No minimum reported
similar: $10,000–$50,000
2018–2025

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Timeline of offerings

SourceFiledIssuerFormIndustryOfferedSold
EDGAR ↗Nov 13, 2025ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$4,000,000$4,000,000
EDGAR ↗Apr 9, 2025ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$3,600,000$3,600,000
EDGAR ↗Feb 12, 2025ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$600,000$600,000
EDGAR ↗Dec 1, 2023ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$6,999,988$6,999,988
EDGAR ↗Sep 29, 2022ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$5,000,000$5,000,000
EDGAR ↗Feb 18, 2021ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$5,499,971$4,199,985
EDGAR ↗Aug 17, 2020ELIXIRGEN THERAPEUTICS, INC.D/ABiotechnology$5,706,889$5,706,889
EDGAR ↗Dec 2, 2019ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$5,006,900$5,006,900
EDGAR ↗Jun 25, 2018ELIXIRGEN THERAPEUTICS, INC.DBiotechnology$3,999,998$3,999,998
EDGAR ↗Apr 23, 2012Elixirgen, LLCDBiotechnology$1,000,000$300,000

Activity: 1 new offering in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Nov 13, 2025. Industry history, as reported on each offering's latest filing: All 9 offerings reported: Biotechnology (2012–2025).

People across the group

NameRolesIssuers hereFirst → last listed
MK Minoru KoDirector, Executive Officer2Apr 23, 2012 → Nov 13, 2025
HK HIROAKI KOBAYASHIDirector1Feb 18, 2021 → Nov 13, 2025
JC JEFFREY CLELANDDirector1Dec 1, 2023 → Nov 13, 2025
SC SHAUNA CALLAHANDirector1Feb 18, 2021 → Nov 13, 2025
AK AKIHIRO KOExecutive Officer, Director, Promoter1Jun 25, 2018 → Nov 13, 2025
TW THOMAS WHITEDirector1Feb 18, 2021 → Nov 13, 2025
MK Maiko KatadaeDirector1Dec 2, 2019 → Sep 29, 2022
NK Naonori KurokawaDirector1Dec 2, 2019 → Feb 18, 2021
NK Naomi Takahashi KoExecutive Officer1Apr 23, 2012 → Apr 23, 2012

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Elixirgen.

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for Elixirgen as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Public profiles and social

No website or social profile named in Elixirgen's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #54,808 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Export this report as PDF · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Change history

No corrections have been requested for this page.

Request a correction

Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.

Sponsor response

Add a sourced explanation next to any fact. Reviewed before publishing.

Grouping is PartnerFacts' inference from public filings (shared related persons, management entities, business address). Everything else on this page is drawn from the filings themselves. Not the same sponsor? Request a correction.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (outside the US (as filed: BALTIMORE), MD). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Maryland Judiciary case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Maryland Secretary of State business search ↗OpenCorporates ↗